$564 Million is the total value of Essex Woodlands Management, Inc.'s 9 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABMD | Sell | ABIOMED INC | $159,634,000 | -23.2% | 946,818 | -34.7% | 28.32% | -24.6% |
| RVNC | REVANCE THERAPEUTICS INC | $126,511,000 | +4.4% | 4,592,047 | 0.0% | 22.44% | +2.4% | |
| CORI | CORIUM | $103,635,000 | +48.5% | 9,353,304 | 0.0% | 18.39% | +45.7% | |
| AXGN | AXOGEN INC | $94,062,000 | +15.5% | 4,861,111 | 0.0% | 16.69% | +13.3% | |
| ENTL | ENTELLUS MEDICAL INC | $59,656,000 | +11.5% | 3,231,656 | 0.0% | 10.58% | +9.4% | |
| ELGX | ENDOLOGIX INC | $11,415,000 | -2.4% | 1,257,468 | 0.0% | 2.02% | -4.3% | |
| MNOV | MEDICINOVA INC | $7,455,000 | +21.1% | 1,170,370 | 0.0% | 1.32% | +18.9% | |
| ACUR | ACURA PHARMACEUTICALS INC | $880,000 | -19.7% | 1,956,397 | 0.0% | 0.16% | -21.2% | |
| CBIO | CATALYST | $404,000 | +8.6% | 78,622 | 0.0% | 0.07% | +7.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MEDICINOVA INC | 42 | Q3 2023 | 6.5% |
| REVANCE THERAPEUTICS INC | 39 | Q3 2023 | 44.6% |
| AXOGEN INC | 26 | Q4 2021 | 43.3% |
| ENDOLOGIX INC | 24 | Q1 2019 | 22.5% |
| ABIOMED INC | 20 | Q1 2018 | 52.1% |
| CORIUM INTL INC | 20 | Q1 2019 | 23.5% |
| TELA BIO, INC. | 16 | Q3 2023 | 31.5% |
| VENUS CONCEPT, INC. | 16 | Q3 2023 | 21.3% |
| ACURA PHARMACEUTICALS INC | 15 | Q1 2019 | 1.4% |
| CATALYST BIOSCIENCES INC | 15 | Q1 2019 | 1.0% |
View Essex Woodlands Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Essex Woodlands Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.